EUVIMEDEUVIMED entdecken
Open Access

Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA

Aniket Jana iD, Moumita Jash iD, Samya Sen iD, Dipro Mukherjee, Surojit Ghosh, Sandip Sarkar, Satyajit Ghosh, Rajsekhar Roy, Monika Singh, Subhadra Nandi iD, Priya Rajdev, Surajit Ghosh iD und 2 weitere

Angewandte Chemie International Edition · 10.08.2026 · 65 (33)

DOI: 10.1002/anie.5919230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 10.06.2026. Verfasst von Aniket Jana und 13 weiteren Autor:innen. Beteiligte Einrichtung: Smart Healthcare, Interdisciplinary Research Division, Indian Institute of Technology, Jodhpur, Karwar, Rajasthan, India. Hauptthemen laut MEDLINE: Thiophenes, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Uridine Diphosphate N-Acetylmuramic Acid. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Engineering Research Board (currently ANRF), DST, Govt. of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin‐resistant Staphylococcus aureus (MRSA) remains a significant global health threat, necessitating the development of new antimicrobials. We report the rational design of a small molecule TPL(II)‐07, that combines multiple functional modules: (i) 2‐phenylthiophene for specific recognition and binding to lipid II, a key intermediate in peptidoglycan biosynthesis; (ii) an adamantane fragment with high interfacial permeability to destabilize lipid packing; (iii) a cationic lysine moiety to disperse biofilms; and (iv) a moderate aliphatic chain to disrupt membrane integrity. Among seven analogues, TPL(II)‐07 exhibited the highest potency, highlighting the synergistic contribution of each component. Mechanistic assays confirmed preferential binding of lipid II, bactericidal potency, biofilm dispersion, and the generation of reactive oxygen species, effective against both drug‐resistant (MIC 19 µM) and drug‐sensitive (MIC 9 µM) S. aureus strains. TPL(II)‐07 demonstrated excellent biocompatibility, with IC 50 > 50 mM in HEK‐293 and WI38 cells and negligible hemolytic activity. In addition, it suppressed key virulence traits, including hemolysin activity, biofilm formation, and staphyloxanthin production. Further, a borate‐functionalized guar gum hydrogel incorporating TPL(II)‐07 achieved effective infection control and enhanced wound repair in a murine excisional model, establishing thiophene‐based lipid II targeting as a versatile platform for next‐generation antimicrobials with dual antibacterial and wound‐healing potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsUridine Diphosphate N-Acetylmuramic AcidMicrobial Sensitivity TestsHumansBiofilmsAnimals

Stichwörter der Autor:innen

2‐Phenylthiophene hybridslipid II targetingmembrane depolarizationwound‐healing hydrogel

Substanzen

ThiophenesAnti-Bacterial AgentsUridine Diphosphate N-Acetylmuramic Acidmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol

Autor:innen und Institutionen

  • Smart Healthcare, Interdisciplinary Research Division, Indian Institute of Technology, Jodhpur, Karwar, Rajasthan, India.
  • Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Karwar, Rajasthan, India.
  • iHUB Drishti Foundation, Indian Institute of Technology, Jodhpur, Karwar, Rajasthan, India.
  • Current Address: Department of Microbiology, Techno India University, Kolkata, West Bengal, India.
  • Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Nadia, West Bengal, India.
  • Central Research Facility (CRF), Indian Institute of Technology, Jodhpur, Karwar, Rajasthan, India.

ORCID-Profile: Aniket Jana, Moumita Jash, Samya Sen, Subhadra Nandi, Surajit Ghosh, Jayita Sarkar, Amitava Das

Förderung

  • Science and Engineering Research Board (currently ANRF), DST, Govt. of India

Zitieren

APA

Jana, A., Jash, M., Sen, S., Mukherjee, D., Ghosh, S., Sarkar, S., Ghosh, S., Roy, R., Singh, M., Nandi, S., Rajdev, P., Ghosh, S., Sarkar, J., & Das, A. (2026). Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA. Angewandte Chemie International Edition, 65(33). https://doi.org/10.1002/anie.5919230

Vancouver

Jana A, Jash M, Sen S, Mukherjee D, Ghosh S, Sarkar S, et al. Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA. Angewandte Chemie International Edition. 2026;65(33). doi:10.1002/anie.5919230

BibTeX
@article{Jana2026,
  author = {Jana, Aniket and Jash, Moumita and Sen, Samya and Mukherjee, Dipro and Ghosh, Surojit and Sarkar, Sandip and Ghosh, Satyajit and Roy, Rajsekhar and Singh, Monika and Nandi, Subhadra and Rajdev, Priya and Ghosh, Surajit and Sarkar, Jayita and Das, Amitava},
  title = {Thiophene‐Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {33},
  doi = {10.1002/anie.5919230}
}
Kostenlos starten →